health

A new brain network responsible for complex movements may upend what we know about neural maps in primary motor areas

Colonizing tumors with engineered bacteria may allow researchers to target sites currently inaccessible to radionuclide therapy.

Low levels of the clotting factor HSP47 protect the sleeping giants from blood clots, and the same may be possible for humans and other mammals.

A battery that charges itself in salty fluids starves tumors of oxygen, helping improve some drugs treat cancer, a study finds.

An implantable device stimulates muscle contraction and prevents muscular atrophy in mice.

The experimental device, known as MAGENTA, forces muscles to contract, simulating natural movement. 

Researchers find many tumor-specific antigens form when cancer genes and transposable elements link up.

Regulatory T cells in the colon travel to muscles to promote wound healing in mice, raising questions about how antibiotics may impact injury recovery.

Researchers find that bacteria stimulate a headache-causing pain pathway to suppress the immune system and infect the brain. 

Researchers find that an increased heart rate can induce anxiety in mice, given the right context.

DNA sequencing can identify mutations that predict recurrence of renal cell carcinoma and may help low-risk patients avoid unnecessary treatment, a study finds.

A therapy for type 1 diabetes is the first to treat patients before symptoms appear, paving the way toward preventing this and other autoimmune diseases.

The “wound current” has intrigued scientists for more than a century. It could turn out to be the key to healing catastrophic injuries.

Synthetic variations of squalene, which is used to boost immune responses, could make vaccines more effective while reducing fisheries for struggling sharks.

Two studies find that tumor-specific antigens are often peptides that result from a splicing event between exons and transposable elements.

Researchers find that small sacks inside lymph nodes contain low proteolytic activity and act as safe havens for antigens.

Where and how human papillomavirus integrates itself into the human genome steers the infection’s clinical outcomes, finds a large, multifaceted study.